January 21, 2022
1 min read
Save
DREAM-HF
Issue: January 2022
Allogeneic mesenchymal precursor cells to treat persistent HF with reduced ejection fraction.
Allogeneic mesenchymal precursor cells to treat persistent HF with reduced ejection fraction.